No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...

Recent history makes clear that microbiological disasters can strike anytime. But a longer history should remind us of the ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

To learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and ...

vaccines offer great potential to mitigate a future pandemic. Influenza A(H5N1) is classified as a highly pathogenic avian influenza virus that predominately affects wild birds and poultry.